Healthcare at Home Ltd., Burton upon Trent, UK.
UCB Pharma, Brussels, Belgium.
Adv Ther. 2020 Apr;37(4):1522-1535. doi: 10.1007/s12325-020-01257-6. Epub 2020 Mar 2.
The CIMZIA AutoClicks pre-filled pen (CZP PFP) was developed to overcome barriers to self-injection, by improving self-injection confidence, reducing fear associated with needle use, and supporting patients with impaired dexterity. The purpose of this research was to gather feedback on injection experience and the usefulness of training materials.
Eligible patients with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA) were at least 18 years of age and initiated onto the CZP PFP. Routine self-injection training and support were provided by trained specialist nurses. Patient experience (pain and skin reactions, confidence, satisfaction, and ease of use) was evaluated at visits 1-3 using an amended version of the self-injection assessment questionnaire (SIAQ) v2.0. Nurse and patient feedback on the training materials, and nurse opinions on patient self-injection after self-injection at visit 1, were also collected.
Of 355 patients invited to participate, 196 provided informed consent and 79 participated in all three visits. Patients generally found the CZP PFP easy to use, and self-confidence and satisfaction were high. From visit 1 to visit 3, there was a numerical trend towards improvement in all three aspects of patient experience, most notably in both confidence and satisfaction. After self-injection at visit 1, confidence around safe patient self-injection was higher among nurses than among patients. Meanwhile, "pain and skin reactions" remained low at all visits. Patients thought the training materials contained sufficient information and were easy to understand and useful.
After training, patients generally found the device easy to use and showed high confidence and satisfaction with self-injection. Some patients may have been competent (based on nurse opinion), but initially lacked self-confidence. Increasing self-injection experience, together with patient training and continued support, may have facilitated high patient confidence and satisfaction, thereby potentially overcoming some of the barriers to self-injection.
为了克服自我注射的障碍,提高自我注射的信心,减少与使用针头相关的恐惧,并为手部灵活性受损的患者提供支持,开发了 CIMZIA AutoClicks 预充式笔(CZP PFP)。本研究旨在收集关于注射体验和培训材料有用性的反馈。
符合条件的类风湿关节炎(RA)、轴性脊柱关节炎(axSpA)或银屑病关节炎(PsA)患者年龄至少为 18 岁,并开始使用 CZP PFP。经过培训的专科护士提供常规的自我注射培训和支持。使用修订版自我注射评估问卷(SIAQ)v2.0 在就诊 1-3 时评估患者体验(疼痛和皮肤反应、信心、满意度和易用性)。还收集了护士对培训材料的反馈以及护士对患者在就诊 1 时自我注射后的自我注射意见。
在 355 名受邀参与的患者中,有 196 名提供了知情同意书,有 79 名患者参加了所有三次就诊。患者普遍认为 CZP PFP 使用方便,信心和满意度较高。从就诊 1 到就诊 3,患者体验的所有三个方面都呈现出数值上的改善趋势,尤其是信心和满意度方面。就诊 1 时进行自我注射后,护士对安全患者自我注射的信心高于患者。同时,所有就诊时“疼痛和皮肤反应”均较低。患者认为培训材料包含足够的信息,易于理解和有用。
经过培训,患者普遍发现该设备易于使用,对自我注射具有高度的信心和满意度。一些患者可能有能力(基于护士的意见),但最初缺乏信心。增加自我注射经验,结合患者培训和持续支持,可能有助于提高患者的信心和满意度,从而可能克服一些自我注射的障碍。